HHS Launches Initiative to End Animal Testing; Modernizes Medical Research Rules
The Department of Health and Human Services announced over 20 initiatives to shift from animal testing to alternative methods like organoids and AI. The FDA removed animal-testing references from regulations, and NIH closed its last intramural beagle lab.
On September 21, 2026, HHS announced over 20 initiatives to transition toward human-based research methods, such as organoids and AI, to reduce animal testing, with Secretary Robert F. Kennedy, Jr. stating the goal is to "modernize outdated regulations" and "end unnecessary animal testing".
The FDA issued a final rule removing animal testing references, while NIH closed its last intramural beagle lab, the CDC is reducing its animal colony, and ARPA-H is utilizing AI through its CATALYST program to enhance drug safety predictions.
What This Means for Patients and Researchers
This shift represents a significant modernization of US medical research infrastructure. For expats working in or studying pharmaceutical development, biotech, or medical research, the regulatory environment is becoming more favorable to cutting-edge, humane alternatives. Drug development timelines may accelerate with AI-assisted safety testing, and researchers using newer methods may face fewer regulatory hurdles. If you're in healthcare, life sciences, or related fields, these regulatory changes open opportunities for careers in emerging research technologies.
Sources
Independent app, not a government. General information, not advice. The official source:
